Terms: = Thyroid cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Staging
13 results:
1. How do
Mukhtar N; Alhamoudi K; Alswailem M; Alhindi H; Murugan AK; Alghamdi B; Alzahrani AS
Front Endocrinol (Lausanne); 2023; 14():1270796. PubMed ID: 37859987
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Pathology of Non-familial Follicular Epithelial-Derived thyroid cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
Soares P; Póvoa AA; Melo M; Vinagre J; Máximo V; Eloy C; Cameselle-Teijeiro JM; Sobrinho-Simões M
Endocr Pathol; 2021 Mar; 32(1):44-62. PubMed ID: 33651322
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of
van Ipenburg JA; Naus NC; Dubbink HJ; van Ginderdeuren R; Missotten GS; Paridaens D; Verdijk RM
Br J Ophthalmol; 2021 Oct; 105(10):1454-1461. PubMed ID: 33127831
[TBL] [Abstract] [Full Text] [Related]
4. Using The cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on cancer staging for papillary thyroid carcinoma.
Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
[TBL] [Abstract] [Full Text] [Related]
5. Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary thyroid cancer.
Suh S; Goh TS; Kim YH; Oh SO; Pak K; Seok JW; Kim IJ
Endocrinol Metab (Seoul); 2020 Jun; 35(2):435-442. PubMed ID: 32615728
[TBL] [Abstract] [Full Text] [Related]
6. [Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms].
Cameselle-Teijeiro JM; Bella Cueto MR; Eloy C; Abdulkader I; Amendoeira I; Matías-Guiu X; Sobrinho-Simões M
Rev Esp Patol; 2020; 53(1):27-36. PubMed ID: 31932006
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Parameters in Differentiated thyroid Carcinomas.
Cipriani NA
Surg Pathol Clin; 2019 Dec; 12(4):883-900. PubMed ID: 31672296
[TBL] [Abstract] [Full Text] [Related]
8. Impact of BRAF V600E and tert Promoter Mutations on Response to Therapy in Papillary thyroid cancer.
Trybek T; Walczyk A; Gąsior-Perczak D; Pałyga I; Mikina E; Kowalik A; Hińcza K; Kopczyński J; Chrapek M; Góźdź S; Kowalska A
Endocrinology; 2019 Oct; 160(10):2328-2338. PubMed ID: 31305897
[TBL] [Abstract] [Full Text] [Related]
9. Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung cancer.
Stinchcombe TE
Oncologist; 2017 Dec; 22(12):1510-1517. PubMed ID: 28778960
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Markers Involved in Tumorigenesis of thyroid Carcinoma: Focus on Aggressive Histotypes.
Penna GC; Vaisman F; Vaisman M; Sobrinho-Simões M; Soares P
Cytogenet Genome Res; 2016; 150(3-4):194-207. PubMed ID: 28231576
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic effects of tert promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Song YS; Lim JA; Choi H; Won JK; Moon JH; Cho SW; Lee KE; Park YJ; Yi KH; Park DJ; Seo JS
Cancer; 2016 May; 122(9):1370-9. PubMed ID: 26969876
[TBL] [Abstract] [Full Text] [Related]
12. ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome.
Tavares C; Melo M; Cameselle-Teijeiro JM; Soares P; Sobrinho-Simões M
Eur J Endocrinol; 2016 Apr; 174(4):R117-26. PubMed ID: 26510840
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative Assessment of tert Promoter Mutation on thyroid Core Needle Biopsies Supports Diagnosis of Malignancy and Addresses Surgical Strategy.
Crescenzi A; Trimboli P; Modica DC; Taffon C; Guidobaldi L; Taccogna S; Rainer A; Trombetta M; Papini E; Zelano G
Horm Metab Res; 2016 Mar; 48(3):157-62. PubMed ID: 25951319
[TBL] [Abstract] [Full Text] [Related]
